Zbigniew K. Wszolek focuses on Genetics, Parkinsonism, Pathology, Disease and Mutation. Zbigniew K. Wszolek usually deals with Genetics and limits it to topics linked to Frontotemporal lobar degeneration and Allele and Charged multivesicular body protein 2B. His Parkinsonism research is multidisciplinary, relying on both Frontotemporal dementia and parkinsonism linked to chromosome 17, Parkinson's disease, LRRK2 and Haplotype.
Zbigniew K. Wszolek regularly links together related areas like Dopaminergic in his Pathology studies. His research in Disease tackles topics such as Central nervous system disease which are related to areas like Pediatrics. The various areas that he examines in his Mutation study include Splice site mutation and Genetic linkage.
His primary areas of study are Genetics, Parkinsonism, Pathology, Disease and Parkinson's disease. His study in Genetics concentrates on Mutation, Gene, Haplotype, Locus and Allele. His Parkinsonism study incorporates themes from Dementia, Frontotemporal dementia, Neurology, Neuroscience and Pediatrics.
His study in Frontotemporal dementia is interdisciplinary in nature, drawing from both Amyotrophic lateral sclerosis and Tau protein. Zbigniew K. Wszolek interconnects Phenotype, Allele frequency, Pathological and Bioinformatics in the investigation of issues within Disease. His work in LRRK2 and Alpha-synuclein is related to Parkinson's disease.
Disease, Pathology, Frontotemporal dementia, Genetics and Internal medicine are his primary areas of study. His Disease research is multidisciplinary, relying on both Odds ratio and Bioinformatics. His biological study deals with issues like Mutation, which deal with fields such as Asymptomatic.
His research investigates the connection with Frontotemporal dementia and areas like Tau protein which intersect with concerns in Haplotype. Genetics and Ataxia are frequently intertwined in his study. Zbigniew K. Wszolek has included themes like Apathy and Age of onset in his Parkinsonism study.
His primary areas of investigation include Pathology, Frontotemporal dementia, Disease, Progressive supranuclear palsy and Genetics. His study in Parkinsonism, Dementia with Lewy bodies, Atrophy and Neuropathology falls within the category of Pathology. His study in Age of onset extends to Parkinsonism with its themes.
His studies in Frontotemporal dementia integrate themes in fields like Tau protein and Likely pathogenic. Zbigniew K. Wszolek studies Disease, namely Parkinson's disease. His study in Mutation, Genome-wide association study, Sanger sequencing, Genetic association and Missense mutation are all subfields of Genetics.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS
Mariely DeJesus-Hernandez;Ian R. Mackenzie;Bradley F. Boeve;Adam L. Boxer.
Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology
Alexander Zimprich;Alexander Zimprich;Saskia Biskup;Petra Leitner;Peter Lichtner.
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease.
Paul Hollingworth;Denise Harold;Rebecca Sims;Amy Gerrish.
Nature Genetics (2011)
Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study
Daniel G Healy;Mario Falchi;Sean S O'Sullivan;Vincenzo Bonifati.
Lancet Neurology (2008)
Mutation-Specific Functional Impairments in Distinct Tau Isoforms of Hereditary FTDP-17
Ming Hong;Victoria Zhukareva;Vanessa Vogelsberg-Ragaglia;Zbigniew Wszolek.
VPS35 Mutations in Parkinson Disease
Carles Vilariño-Güell;Christian Wider;Owen A. Ross;Justus C. Dachsel.
American Journal of Human Genetics (2011)
Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria.
Dennis W Dickson;Heiko Braak;John E Duda;Charles Duyckaerts.
Lancet Neurology (2009)
Comparison of kindreds with parkinsonism and α‐synuclein genomic multiplications
Matt Farrer;Jennifer Kachergus;Lysia Forno;Sarah Lincoln.
Annals of Neurology (2004)
A susceptibility locus for Parkinson's disease maps to chromosome 2p13
Thomas Gasser;Bertram Müller-Myhsok;Zbigniew K. Wszolek;Ralph Oehlmann.
Nature Genetics (1998)
DLB and PDD boundary issues: Diagnosis, treatment, molecular pathology, and biomarkers
C. F. Lippa;J. E. Duda;M. Grossman;H. I. Hurtig.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: